IL33-ST2 axis is a predictive biomarker for anti-PD1 therapeutic efficacy in advanced gastric cancer.

Kudo-Saito C, Imazeki H, Nagashima K, Shoji H, Tsugaru K, Takahashi N, Kawakami T, Amanuma Y, Wakatsuki T, Okano N, Narita Y, Yamamoto Y, Kizawa R, Muro K, Ichikawa H, Boku N

Open source

DOI
10.1186/s12967-025-07145-3
Published
2025 Oct 17
Container
Journal of translational medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12967-025-07145-3,
  title = {IL33-ST2 axis is a predictive biomarker for anti-PD1 therapeutic efficacy in advanced gastric cancer.},
  author = {Kudo-Saito C and Imazeki H and Nagashima K and Shoji H and Tsugaru K and Takahashi N and Kawakami T and Amanuma Y and Wakatsuki T and Okano N and Narita Y and Yamamoto Y and Kizawa R and Muro K and Ichikawa H and Boku N},
  year = {2025},
  journal = {Journal of translational medicine},
  doi = {10.1186/s12967-025-07145-3},
  url = {https://doi.org/10.1186/s12967-025-07145-3}
}

RIS

TY  - JOUR
TI  - IL33-ST2 axis is a predictive biomarker for anti-PD1 therapeutic efficacy in advanced gastric cancer.
AU  - Kudo-Saito C
AU  - Imazeki H
AU  - Nagashima K
AU  - Shoji H
AU  - Tsugaru K
AU  - Takahashi N
AU  - Kawakami T
AU  - Amanuma Y
AU  - Wakatsuki T
AU  - Okano N
AU  - Narita Y
AU  - Yamamoto Y
AU  - Kizawa R
AU  - Muro K
AU  - Ichikawa H
AU  - Boku N
PY  - 2025
JO  - Journal of translational medicine
DO  - 10.1186/s12967-025-07145-3
UR  - https://doi.org/10.1186/s12967-025-07145-3
ER  - 

APA

C, K., H, I., K, N., H, S., K, T., N, T., T, K., Y, A., T, W., N, O., Y, N., Y, Y., R, K., K, M., H, I., & N, B. (2025). IL33-ST2 axis is a predictive biomarker for anti-PD1 therapeutic efficacy in advanced gastric cancer.. Journal of translational medicine. https://doi.org/10.1186/s12967-025-07145-3

Source records